ДЕФИЦИТ ВИТАМИНА Д У ЖЕНЩИН В МЕНОПАУЗЕ (ОБЗОР ЛИТЕРАТУРЫ)
Аннотация
Библиографические ссылки
Бодяйина В.И., Жмакин К.Н. Гинекология, Т :, “Медицина” 11, 1979.
Татарин Н.А. и др. Гинекология. Новейший справочник, М. : Санкт-Петербург 2006.
Загребина В.А., Торчинов А.М. Гинекология. М. :, “М е д и ц и н а” 11, 1987.
Руководство по проведению исследования тонкого кишечника и органов малого тельца, Американское агентство по международному развитию (USAID)
Журнал "Медицинский экспресс".
Kellum, J. A., Lameire, N. & Group, K. A. G. W. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Critical care 17, 204 (2019).
Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors Influencing Serum Cystatin C Levels Other Than Renal Function and the Impact on Renal Function Measurement. Kidney Int (2020) 65(4):1416–21. doi: 10.1111/j.1523-1755.2004.00517.x
Lafarge JC, Naour N, Clément K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie. 2020; 92(11): 1580-6.
Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK, Grønbæk H. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. World J Hepatol. 2019 Feb 27;11(2):138-149.
Lavrenova E.A., Drapkina O.M. Insulin resistance in obesity: causes and consequences // Obesity and metabolism. – 2020. – T. 17. – №1. – C. 48-55. doi: https://doi.org/10.14341/omet9759.
Lin H-Y, Shao-Wen W, Shen FC. Abrogation of Toll-like receptor 4 (TLR4) mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria in adipose tissue. Antioxid Redox Signal. 2020;33(2):1–60. doi:10.1089/ars.2019.7737
Marmarinos A, Garoufi A, Panagoulia A, Dimou S, Drakatos A, Paraskakis I, et al. Cystatin-C levels in healthy children and adolescents: Influence of age, gender, body mass index and blood pressure. Clin Biochem. 2016; 49(1): 150-3.
Mathisen, U. D. et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J. Am. Soc. Nephrol. 22, 927–937 (2021).
